Franklin Resources
BOLD

Franklin Resources’s Audentes Therapeutics, Inc BOLD Stock Holding History

Franklin Resources’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-235,552
Closed -$6.62M – 1596
2019
Q3 		$6.62M Buy
235,552
+2,866
+1% +$97.8K ﹤0.01% 945
2019
Q2 		$8.81M Buy
+232,686
New +$8.94M ﹤0.01% 922
2018
Q4 		– Sell
-401,100
Closed -$15.9M – 1557
2018
Q3 		$15.9M Buy
401,100
+5,900
+1% +$220K 0.01% 836
2018
Q2 		$15.1M Buy
395,200
+47,100
+14% +$1.74M 0.01% 839
2018
Q1 		$10.5M Hold
348,100
– – 0.01% 917
2017
Q4 		$10.9M Sell
348,100
-19,000
-5% -$522K 0.01% 922
2017
Q3 		$10.3M Hold
367,100
– – 0.01% 937
2017
Q2 		$7.02M Hold
367,100
– – ﹤0.01% 1030
2017
Q1 		$6.25M Hold
367,100
– – ﹤0.01% 1065
2016
Q4 		$6.71M Hold
367,100
– – ﹤0.01% 1042
2016
Q3 		$6.54M Buy
+367,100
New +$5.57M ﹤0.01% 1060

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Franklin Resources's BOLD Position: Q4 2019 in Review

Franklin Resources sold out of Audentes Therapeutics, Inc (BOLD) in Q4 2019, closing a stake of 235,552 shares — an estimated $6.62M sold.

Franklin Resources first reported a position in BOLD in Q3 2016 and held it in 11 quarters. The position peaked at $15.9M in Q3 2018. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Franklin Resources reported no remaining Audentes Therapeutics, Inc position as of Q4 2019 after selling out during the quarter.
  • Franklin Resources sold 235,552 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $6.62M.
  • Franklin Resources first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 11 quarters.
  • Franklin Resources's Audentes Therapeutics, Inc position peaked at $15.9M in Q3 2018.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Franklin Resources's 13F filing for Q4 2019, filed 12 Feb 2020.